160 related articles for article (PubMed ID: 6396766)
61. Adjuvant therapy in breast cancer.
Dorr A
Curr Opin Oncol; 1990 Dec; 2(6):1049-52. PubMed ID: 2099836
[No Abstract] [Full Text] [Related]
62. The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Levine MN; Bramwell V; Abu-Zahra H; Goodyear MD; Arnold A; Findlay B; Skillings J; Gent M
Br J Cancer; 1992 Jan; 65(1):130-2. PubMed ID: 1733435
[TBL] [Abstract][Full Text] [Related]
63. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
[TBL] [Abstract][Full Text] [Related]
64. Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.
Ragaz J
Recent Results Cancer Res; 1986; 103():85-94. PubMed ID: 3526477
[No Abstract] [Full Text] [Related]
65. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
Albain KS
J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
[No Abstract] [Full Text] [Related]
66. The role of surgery in the combined treatment of locally advanced breast cancer.
Canavese G; Catturich A; Battistini G; Caroti C; Pronzato P; Gardin G; Amoroso D; Bertelli G; Conte PF; Tomao S
Oncology; 1989; 46(6):353-6. PubMed ID: 2587002
[TBL] [Abstract][Full Text] [Related]
67. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
Ahmann FR; Jones SE; Moon TE
J Surg Oncol; 1988 Feb; 37(2):116-22. PubMed ID: 3343839
[TBL] [Abstract][Full Text] [Related]
68. [Treatment of locally advanced cancer of the breast].
Lluch A; Pascual A; Cervantes A; Antón A; Martínez Agulló A; Aviñó J; Alberola V; García-Conde J
Med Clin (Barc); 1987 May; 89(1):7-10. PubMed ID: 3613742
[No Abstract] [Full Text] [Related]
69. Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Pfeiffer P; Cold S; Rose C
Acta Oncol; 1992; 31(2):219-24. PubMed ID: 1622637
[TBL] [Abstract][Full Text] [Related]
70. Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Carbone PP
Breast Cancer Res Treat; 1983; 3 Suppl():S35-8. PubMed ID: 6367858
[TBL] [Abstract][Full Text] [Related]
71. Local management in primary breast cancer. Our experience of 331 cases.
Appelqvist P; Salmo M; Leivonen M; Kalima T; Saario I; Tolppanen EM
Strahlenther Onkol; 1987 Oct; 163(10):643-7. PubMed ID: 3672311
[TBL] [Abstract][Full Text] [Related]
72. Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.
Fisher B
Recent Results Cancer Res; 1986; 103():54-68. PubMed ID: 3526476
[No Abstract] [Full Text] [Related]
73. [Adjuvant chemotherapy and mastectomy].
Veselý F; Pelikán A
Rozhl Chir; 1988 Jul; 67(7):455-60. PubMed ID: 3175776
[No Abstract] [Full Text] [Related]
74. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.
Perloff M; Norton L; Korzun AH; Wood WC; Carey RW; Gottlieb A; Aust JC; Bank A; Silver RT; Saleh F; Canellos GP; Perry MC; Weiss RB; Holland JF
J Clin Oncol; 1996 May; 14(5):1589-98. PubMed ID: 8622076
[TBL] [Abstract][Full Text] [Related]
75. Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer.
Panasci LC
J Clin Oncol; 2006 May; 24(15):2392; author reply 2392. PubMed ID: 16710042
[No Abstract] [Full Text] [Related]
76. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
77. Randomized multicenter 2 x 2-factorial design study of chemo/endocrine therapy in operable, node-positive breast cancer (protocol 2).
Scheurlen H
Recent Results Cancer Res; 1989; 115():226-35. PubMed ID: 2696037
[No Abstract] [Full Text] [Related]
78. The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.
Kojima T; Hoshino A; Ohara K; Kamiya O; Nagata K; Ito Y; Kinoshita T; Sugiura I; Yamada M; Sato H
Cancer Chemother Pharmacol; 1985; 15(3):268-71. PubMed ID: 3902267
[TBL] [Abstract][Full Text] [Related]
79. A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study.
Wood WC; Weiss RB; Tormey DC; Holland JF; Henry PH; Leone LA; Rafla S; Silver RT; Carey RW; Lesnick GJ
World J Surg; 1985 Oct; 9(5):714-8. PubMed ID: 3840627
[No Abstract] [Full Text] [Related]
80. Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Buzdar AU; Hortobagyi GN; Smith TL; Kau S; Marcus C; Holmes FA; Hug V; Fraschini G; Ames FC; Martin RG
Cancer; 1988 Nov; 62(10):2098-104. PubMed ID: 3179922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
